Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34826413

Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2021 Dec
First author
Murai K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Murai K
      type
      Author
    2. name
      Ureshino H
      type
      Author
    3. name
      Kumagai T
      type
      Author
    4. name
      Tanaka H
      type
      Author
    5. name
      Nishiwaki K
      type
      Author
    6. name
      Wakita S
      type
      Author
    7. name
      Inokuchi K
      type
      Author
    8. name
      Fukushima T
      type
      Author
    9. name
      Yoshida C
      type
      Author
    10. name
      Uoshima N
      type
      Author
    11. name
      Kiguchi T
      type
      Author
    12. name
      Mita M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Murai K
      type
      Author
    2. name
      Ureshino H
      type
      Author
    3. name
      Kumagai T
      type
      Author
    4. name
      Tanaka H
      type
      Author
    5. name
      Nishiwaki K
      type
      Author
    6. name
      Wakita S
      type
      Author
    7. name
      Inokuchi K
      type
      Author
    8. name
      Fukushima T
      type
      Author
    9. name
      Yoshida C
      type
      Author
    10. name
      Uoshima N
      type
      Author
    11. name
      Kiguchi T
      type
      Author
    12. name
      Mita M
      type
      Author
    bibliography ids
    1. nci-bib-cb7e586a807471cf7dc5447d
    book metadata
    content sha256
    39dbed88e13aa54cc2c1c489ad9f475b742ae1f15a47a3033df126b48d30d261
    document type
    citation
    dois
    1. 10.1016/S2352-3026(21)00333-1
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34826413
    immutable id
    pubmed:34826413@39dbed88e13aa54cc2c1c489ad9f475b742ae1f15a47a3033df126b48d30d261
    journal
    abbreviation
    Lancet Haematol
    issn electronic
    2352-3026
    issn print
    Source null
    issue
    12
    name
    The Lancet. Haematology
    nlm unique id
    101643584
    pages
    e902-e911
    volume
    8
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34826413
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      c12c93648ce9c7c116e723ae8d0d42330242d43534ea8b9ff7ed35088599157e
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2021 Dec
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34826413/
      title
      Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial.

      Preserved source evidence · Not medical advice